WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005034945) USE OF NORPHENAZONE AND COENZYME Q FOR CURING ARTHROSE, ARTHRITIS AND OSTEOARTHRITIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/034945    International Application No.:    PCT/CH2004/000021
Publication Date: 21.04.2005 International Filing Date: 16.01.2004
IPC:
A61K 9/00 (2006.01), A61K 31/122 (2006.01), A61K 31/402 (2006.01), A61K 31/4152 (2006.01), A61K 45/06 (2006.01), A61K 47/02 (2006.01), A61K 47/26 (2006.01), C07D 231/20 (2006.01)
Applicants: SCHWITZGUEBEL, Thierry [CH/CH]; (CH)
Inventors: SCHWITZGUEBEL, Thierry; (CH)
Priority Data:
1735/03 11.10.2003 CH
Title (EN) USE OF NORPHENAZONE AND COENZYME Q FOR CURING ARTHROSE, ARTHRITIS AND OSTEOARTHRITIS
(FR) UTILISATION DE LA NORPHENAZONE ET DE COENZYME Q POUR LE TRAITEMENT DE L'ARTHROSE, L'ARTHRITE ET L'OSTEO-ARTHRITE
Abstract: front page image
(EN)The invention relates to a pharmaceutical preparation containing norphenazone (3-methyl-1-phenyl-2-pyrazolin-5-one) or the pharmaceutically acceptable salts thereof or coenzyme Qn (N ranging from 6 to 10) or the mixture of the components thereof which is very efficient for therapeutically curing arthrose, arthritis and osteoarthritis and for prophylactics during interventions on articulations. The inventive preparation is particularly useful for any surgical intervention on articulations, in particular for arthroscopies and for above-mentioned diseases. Said preparation reduces the Chondrocytes destruction in affected tissues and the degradation of a polymeric matrix encompassing the Chondrocytes of the related articulation cartilage.
(FR)Une préparation pharmaceutique contenant de la Norphenazone (3-methyl-1-phenyl-2-pyrazolin-5-one) ou ses sels acceptables en usage pharmaceutique ou le Coenzyme QN (N compris entre 6 et 10) ou un mélange de ces constituants est très efficace dans le traitement thérapeutique de l'arthrose, l'arthrite, l'ostéo-arthrite et de manière prophylactique lors d'intervention sur les articulations. Cette préparation est particulièrement utile lors de toute intervention chirurgicale sur les articulations, en particulier les arthroscopies, ainsi que lors de conditions déclarées des affections mentionnées ci-dessus. Cette préparation réduit la destruction des Chondrocytes dans les tissus affectés et diminue la dégradation de la matrice polymérique entourant les Chondrocytes du cartilage de l'articulation concernée.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)